SEC Form 4 · accession 0001140361-18-014847
SEELOS THERAPEUTICS, INC. · SEEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Mar 21, 2018
Accepted (ET)
Mar 23, 2018 · 5:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001017491
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants to Purchase Common StockF2,F3 | $0.71 | Mar 21, 2018 | J | 653,409 | D | Jul 12, 2016 | Jan 12, 2023 | Common Stock | 653,409 | 0 | I |
| Warrants to Purchase Common StockF2,F3 | $0.71 | Mar 21, 2018 | J | 653,409 | A | Jul 12, 2016 | Jan 12, 2023 | Common Stock | 653,409 | 653,409 | I |
Explanation of responses
- F1See Exhibit 99.1; Note 1.
- F2See Exhibit 99.1; Note 2.
- F3See Exhibit 99.1; Note 3.